elosulfase alfa
Drug Details
- Generic Name
- elosulfase alfa
- Brand Names
- VIMIZIM
- Application Number
- BLA125460
- Sponsor
- BioMarin International Limited
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION, CONCENTRATE
- Routes
- INTRAVENOUS
- Active Ingredients
- ELOSULFASE ALFA
Indications and Usage
1 INDICATIONS AND USAGE VIMIZIM (elosulfase alfa) is indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome). VIMIZIM is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome). ( 1 )